Related Experiment Video
Updated: Jun 14, 2026

Assessment of Right Ventricular Structure and Function in Mouse Model of Pulmonary Artery Constriction by Transthoracic Echocardiography
Published on: February 3, 2014
Treadmill exercise echocardiography as a predictor of events in patients with left ventricular hypertrophy
Jesús Peteiro1, Alberto Bouzas-Mosquera, Francisco Broullón
1Department of Cardiology, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain. pete@canalejo.org
Insights
Exercise echocardiography (EE) effectively predicts outcomes in patients with coronary artery disease (CAD) and left ventricular hypertrophy (LVH). EE identifies ischemia, a key factor in mortality and major adverse cardiac events (MACE) for this population.
Area of Science:
- Cardiology
- Diagnostic Imaging
- Clinical Outcomes
Background:
- Exercise echocardiography (EE) is recommended for patients with known or suspected coronary artery disease (CAD) and electrocardiogram (ECG) abnormalities.
- Left ventricular hypertrophy (LVH) is linked to poorer outcomes and often presents with resting ECG abnormalities.
- The study aimed to evaluate EE's predictive value for outcomes in patients with known/suspected CAD and LVH.
Purpose of the Study:
- To assess the prognostic value of exercise echocardiography (EE) in patients with known or suspected coronary artery disease (CAD) and left ventricular hypertrophy (LVH).
- To determine if EE can predict all-cause mortality and major adverse cardiac events (MACE) in this specific patient group.
Main Methods:
- Retrospective analysis of 1,058 patients undergoing EE, categorized by the presence or absence of LVH.
- Evaluation of resting and exercise wall motion score index (WMSI) and identification of ischemia based on new/worsening wall motion abnormalities (WMA).
- Endpoints included all-cause mortality and MACE, with a median follow-up of 4.6 years.
Main Results:
- Patients with exercise-induced ischemia showed significantly higher 5-year mortality (15.3%) and MACE rates (13.6%) compared to those without (6.4% and 7.1%, respectively).
- Left ventricular (LV) mass (HR 1.03) and DeltaWMSI (HR 1.94) were independent predictors of mortality in multivariable analysis.
- DeltaWMSI independently predicted MACE in the overall population and in patients with LVH.
Conclusions:
- Left ventricular mass is an independent predictor of mortality, even when considering EE data.
- EE provides crucial prognostic information for predicting adverse events in patients with LVH and known/suspected CAD.
Background:
Exercise echocardiography (EE) is recommended for patients with known/suspected coronary artery disease (CAD) and electrocardiogram (ECG) abnormalities. Left ventricular hypertrophy (LVH) is associated with worse outcome and patients with LVH have frequently resting ECG abnormalities. We sought to assess the value of EE for predicting outcome in patients with known/suspected CAD and LVH.
Methods:
Retrospective analysis over 1,058 patients, classified according to the presence (n = 557) or absence (n = 501) of LVH (LV mass > or =163 g for women, > or =225 g for men) who underwent EE. Wall motion score index (WMSI) was evaluated at rest and with exercise. Ischemia was defined as the development of new or worsening wall motion abnormalities (WMA) with exercise. The endpoints were all-cause mortality and major cardiac events (MACE). Overall, 352 patients (33%) developed new/worsening WMA.
Results:
During a follow-up of 4.6 +/- 4.0 years, 178 patients died and 129 had a MACE. The 5-year mortality and MACE rates were 6.4 and 7.1% in patients without ischemia vs. 15.3 and 13.6% in those with ischemia, respectively (P < 0.001). In the multivariable analysis, LV mass (hazard ratio (HR) 1.03, 95% confidence interval (CI) 1.02-1.04, P = 0.008) and DeltaWMSI (HR 1.94, 95% CI 1.12-3.35, P = 0.02) were independent predictors of mortality. DeltaWMSI was also an independent predictor of MACE in the overall population (P = 0.002) and in patients with LVH (P = 0.04).
Conclusion:
LV mass independently predicts mortality, even when EE data are considered. EE provides significant information for predicting events in patients with LVH and known/suspected CAD.
Related Concept Videos
Exercise Stress Test
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
Imaging Studies for Cardiovascular System II:Types of Echocardiography
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for diagnosing...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
